Citations

Mayo Clinic

Showing 10 of 108523 citations.

Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis
Soldán, M. Mateo Paz , Raman, Mekala R., Gamez, Jeffrey D., Lohrey, Anne K., Pirko, Istvan, Johnson, Aaron J. , Paz Soldán, M Mateo, Chen, Yi , Johnson, Aaron J. , Paz Soldán, M Mateo

Journal of Neuroimaging | April 20, 2015 | Volume: 25 | Issue: 4 | Pages: 595-599

10.1111/jon.12250 | PMID 25893491 Get It

ABSTRACTBACKGROUNDDisability progression in multiple sclerosis (MS) remains incompletely understood. Unlike lesional measures, central nervous system atrophy has a strong correlation with disability. Theiler's murine encephalomyelitis virus infection in SJL/J mice is an established model of progressive MS. We utilized in vivo MRI to quantify brain and spinal cord atrophy in this model and analyzed the temporal relationship between atrophy and disability.METHODSInfected and control mice were followed for 12 months. Disability was assessed periodically using rotarod assay. Volumetric MRI datasets were acquired at 7 Tesla. Ventricular volume and C4‐5 spinal cord cross‐sectional area measurements were performed using Analyze 10.RESULTSAt 3 months, brain atrophy reached statistical significance (P = .005). In contrast, disability did not differ until 4 months post‐infection (P = .0005). Cord atrophy reached significance by 9 months (P = 0.009). By 12 months, brain atrophy resulted in 111.8% increased ventricular volume (P = .00003), while spinal cord cross‐sectional area was 25.6% reduced (P = .001) among cases.CONCLUSIONSOur results suggest that significant brain atrophy precedes and predicts the development of disability, while spinal cord atrophy occurs late and correlates with severe disability. The observed temporal relationship establishes a framework for mechanisms of disability progression and enables further investigations of their underlying substrate.
Treatment of Patellofemoral Cartilage Lesions in the Young, Active Patient
Prince, Matthew, King, Alexander H. , Stuart, Michael, Dahm, Diane L., Krych, Aaron J. , Prince, Matthew R, Krych, Aaron J

Journal of Knee Surgery | April 20, 2015 | Volume: 28 | Issue: 04 | Pages: 285-296

10.1055/s-0035-1549018 | PMID 25892008 Get It

Cardiac Biomarkers
Mair, Johannes , Jaffe, Allan S. , Apple, Fred S. , Jaffe, Allan, Jaffe, Allan S. , Lindahl, Bertil

Disease Markers | April 19, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/370569 | PMID 25960591 Get It

Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in Rat
Hakim, Jeffrey S. , Rad, Melika Esmaeili, Grahn, Peter J. , Chen, Bingkun K. , Schmeichel, Ann M., Isaq, Nasro A., Dadsetan, Mahrokh, Yaszemski, Michael J. , Windebank, Anthony J. , Esmaeili Rad, Melika, Knight, Andrew M, Knight, Andrew M.

Tissue Engineering Part A | April 19, 2015 | Volume: 21 | Issue: 13-14 | Pages: 2099-2114

10.1089/ten.tea.2015.0019 | PMID 25891264 Get It

Alcoholic hepatitis: Can we outwit the Grim Reaper?
Chirapongsathorn, Sakkarin , Kamath, Patrick S. , Shah, Vijay H. , Shah, Vijay

Hepatology | April 18, 2015 | Volume: 62 | Issue: 3 | Pages: 671-673

10.1002/hep.27852 | PMID 25891016 Get It

Minocycline: a bacteriostatic antibiotic with pleiotropic cardioprotective effects
Brenes-Salazar, Jorge A.

Canadian Journal of Physiology and Pharmacology | April 17, 2015 | Volume: 93 | Issue: 10 | Pages: 863-866

10.1139/cjpp-2014-0493 | PMID 26382908 Get It

Minocycline belongs to the family of tetracyclines, which are drugs traditionally approved as antibiotics. Based on preclinical animal cardiac models and clinical neurology trials, this drug has gained special attention as a promising cardiovascular therapeutic agent given its anti-inflammatory, antiapoptotic, antioxidant, and antienzymatic properties. This review focuses on the available evidence for minocycline as a cardioprotective drug, with special attention to mechanisms of action. Ongoing cardiovascular clinical trials are briefly discussed.
Robotic Partial and Radical Nephrectomy in Renal Allograft: Demonstration of Technique
Abdul-Muhsin, Haidar , Castle, Erik P., Katariya, Nitin

Videourology™ | April 17, 2015 | Volume: 29 | Issue: 4 | Pages: No page available

10.1089/vid.2015.0007 Get It

SAGE-Journals-Accessible-Video-Player 10.1089/vid.2015.0007.M1 sj-vid-1-vid-10.1089_vid.2015.0007
Telemonitoring Blood Pressure by Secure Message on a Patient Portal: Use, Content, and Outcomes
North, Frederick , Elrashidi, Muhamad Y. , Ward, William J. , Takahashi, Paul Y. , Ebbert, Jon O. , Ytterberg, Karen L., Tulledge‐Scheitel, Sidna M. , Takahashi, Paul

Telemedicine and e-Health | April 17, 2015 | Volume: 21 | Issue: 8 | Pages: 630-636

10.1089/tmj.2014.0179 | PMID 25885765 Get It

Cardiothoracic Surgery and Lung Cancer
Allen, Mark S.

Lung Cancer Management | April 17, 2015 | Volume: 4 | Issue: 2 | Pages: 55-56

10.2217/lmt.15.8 Get It

Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Grayson, Peter C. , Xu, Lijing, Lim, Noha , Gao, Zhong, Asare, Adam L. , Stone, John H., Seo, Philip , Langford, Carol A. , Hoffman, Gary S., Kallenberg, Cees G. M., Clair, E. William St. , Tchao, Nadia K., Ytterberg, Steven R. , Phippard, Deborah, Kaplan, Mariana J. , Carmona‐Rivera, Carmelo , Specks, Ulrich , Spiera, Robert , Merkel, Peter A. , Monach, Paul A. , Asare, Adam L

Arthritis & Rheumatology | April 17, 2015 | Volume: 67 | Issue: 7 | Pages: 1922-1932

10.1002/art.39153 | PMID 25891759 Get It

ObjectiveTo discover biomarkers involved in the pathophysiology of antineutrophil cytoplasmic antibody–associated vasculitis (AAV) and to determine whether low‐density granulocytes (LDGs) contribute to gene expression signatures in AAV.MethodsThe source of clinical data and linked biologic specimens was a randomized controlled treatment trial in AAV. RNA sequencing of whole blood from patients with AAV was performed during active disease at the baseline visit and during remission 6 months later. Gene expression was compared between patients who met versus those who did not meet the primary trial outcome of clinical remission at 6 months (responders versus nonresponders). Measurement of neutrophil‐related gene expression was confirmed in peripheral blood mononuclear cells (PBMCs) to validate the findings in whole blood. A negative‐selection strategy isolated LDGs from PBMC fractions.ResultsDifferential expression between responders (n = 77) and nonresponders (n = 35) was detected in 2,346 transcripts at the baseline visit (P < 0.05). Unsupervised hierarchical clustering demonstrated a cluster of granulocyte‐related genes, including myeloperoxidase (MPO) and proteinase 3 (PR3). A granulocyte multigene composite score was significantly higher in nonresponders than in responders (P < 0.01) and during active disease than during remission (P < 0.01). This signature strongly overlapped an LDG signature identified previously in lupus (false discovery rate by gene set enrichment analysis <0.01). Transcription of PR3 measured in PBMCs was associated with active disease and treatment response (P < 0.01). LDGs isolated from patients with AAV spontaneously formed neutrophil extracellular traps containing PR3 and MPO.ConclusionIn AAV, increased expression of a granulocyte gene signature is associated with disease activity and decreased response to treatment. The source of this signature is likely LDGs, a potentially pathogenic cell type in AAV.